|
US77276A
(en)
*
|
|
1868-04-28 |
|
Improvement in spring and body braces for vehicles |
|
US166159A
(en)
*
|
|
1875-07-27 |
|
Improvement in calcining-kilns |
|
US113452A
(en)
*
|
|
1871-04-04 |
|
Improvement in table-leaf supports |
|
US3845217A
(en)
*
|
1972-11-16 |
1974-10-29 |
Helsingborg L Ab |
Buffered smoking substitute compositions
|
|
US4321387A
(en)
|
1980-03-21 |
1982-03-23 |
Philip Morris, Incorporated |
Process for the preparation of optically active nicotine analogs
|
|
US4332945A
(en)
|
1981-01-29 |
1982-06-01 |
Philip Morris, Incorporated |
Optically active nicotine analogs and process for their preparation
|
|
US4442292A
(en)
|
1981-01-29 |
1984-04-10 |
Philip Morris Incorporated |
Optically active nicotine analogs and process for their preparation
|
|
US4590278A
(en)
|
1981-01-29 |
1986-05-20 |
Philip Morris Incorporated |
Nicotine analogs
|
|
US4452984A
(en)
|
1981-01-29 |
1984-06-05 |
Philip Morris, Inc. |
Optically active nicotine analogs and process for their preparation
|
|
GB8301659D0
(en)
*
|
1983-01-21 |
1983-02-23 |
Leo Ab |
Smoking substitutes
|
|
GB8317576D0
(en)
*
|
1983-06-29 |
1983-08-03 |
Shaw A S W |
Consumer tobacco products
|
|
US4953572A
(en)
*
|
1985-04-25 |
1990-09-04 |
Rose Jed E |
Method and apparatus for aiding in the reduction of incidence of tobacco smoking
|
|
US4920989A
(en)
*
|
1985-04-25 |
1990-05-01 |
Regents Of The University Of California |
Method and apparatus for aiding in the reduction of incidence of tobacco smoking
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
DE3645036A1
(de)
*
|
1986-11-18 |
1989-01-05 |
Forschungsgesellschaft Rauchen |
Nikotinhaltiges mittel
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US5073380A
(en)
|
1987-07-27 |
1991-12-17 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
|
ATE122353T1
(de)
|
1987-10-05 |
1995-05-15 |
Yamanouchi Pharma Co Ltd |
Heterozyklische spiroverbindungen und ihre herstellung.
|
|
IE62662B1
(en)
*
|
1989-01-06 |
1995-02-22 |
Elan Corp Plc |
Use of nicotine in the treatment of conditions susceptible to said treatment
|
|
US5525351A
(en)
*
|
1989-11-07 |
1996-06-11 |
Dam; Anders |
Nicotine containing stimulant unit
|
|
US5512306A
(en)
*
|
1992-06-19 |
1996-04-30 |
Pharmica Ab |
Smoking substitute
|
|
JP3153551B2
(ja)
|
1991-05-29 |
2001-04-09 |
アボツト・ラボラトリーズ |
認識機能を高めるイソオキサゾールおよびイソチアゾール化合物
|
|
GB9200047D0
(en)
*
|
1992-01-03 |
1992-02-26 |
Univ Alberta |
Nicotine-containing nasal spray
|
|
US5212188A
(en)
*
|
1992-03-02 |
1993-05-18 |
R. J. Reynolds Tabacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5242934A
(en)
*
|
1992-03-02 |
1993-09-07 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5227391A
(en)
*
|
1992-04-10 |
1993-07-13 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5232933A
(en)
*
|
1992-05-21 |
1993-08-03 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
US5248690A
(en)
*
|
1992-07-07 |
1993-09-28 |
R. J. Reynolds Tobacco Company |
Method for treatment of neurodegenerative diseases
|
|
IL107184A
(en)
|
1992-10-09 |
1997-08-14 |
Abbott Lab |
Heterocyclic ether compounds that enhance cognitive function
|
|
US5549906A
(en)
*
|
1993-07-26 |
1996-08-27 |
Pharmacia Ab |
Nicotine lozenge and therapeutic method for smoking cessation
|
|
US6121276A
(en)
|
1994-04-22 |
2000-09-19 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
|
|
US5703100A
(en)
|
1994-11-10 |
1997-12-30 |
Sibia Neurosciences, Inc. |
Modulators of acetylcholine receptors
|
|
IL118279A
(en)
|
1995-06-07 |
2006-10-05 |
Abbott Lab |
Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
|
|
EP0853621A1
(en)
|
1995-09-22 |
1998-07-22 |
Novo Nordisk A/S |
Novel substituted azacyclic or azabicyclic compounds
|
|
US5936088A
(en)
|
1995-09-22 |
1999-08-10 |
Novo Nordisk A/S |
Substituted azacyclic or azabicyclic compounds with affinity and selectivity for nicotinic cholinergic receptors
|
|
ATE240942T1
(de)
|
1995-11-17 |
2003-06-15 |
Merck & Co Inc |
Neue substituierte aryl-verbindungen als acetylcholine receptors modulatoren
|
|
AU2340397A
(en)
|
1996-03-21 |
1997-10-10 |
Mayo Foundation For Medical Education And Research |
Use of nicotine to treat liver disease
|
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
|
GB9614902D0
(en)
*
|
1996-07-16 |
1996-09-04 |
Rhodes John |
Sustained release composition
|
|
US6020335A
(en)
|
1997-02-06 |
2000-02-01 |
Pfizer Inc |
(N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
|
|
US5861423A
(en)
*
|
1997-02-21 |
1999-01-19 |
Caldwell; William Scott |
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
|
|
US6056968A
(en)
|
1997-03-11 |
2000-05-02 |
Darwin Discovery Limited |
Pharmaceutical drug dosage forms providing different release rates
|
|
FR2761072B1
(fr)
|
1997-03-20 |
1999-04-23 |
Synthelabo |
Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
|
|
US5977131A
(en)
|
1997-04-09 |
1999-11-02 |
Pfizer Inc. |
Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
|
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
JP2002511068A
(ja)
|
1997-05-30 |
2002-04-09 |
ニューロサーアチ・アクティーゼルスカブ |
アザシクロオクタン及びヘプタン誘導体、その製造方法及びこれを用いて治療する方法
|
|
JP2002502383A
(ja)
|
1997-05-30 |
2002-01-22 |
ニューロサーアチ・アクティーゼルスカブ |
ニコチンＡＣｈレセプターに於けるコリン作動性リガンドとしての９−アザビシクロ（３．３．１）ノン−２−エン及びノナン誘導体
|
|
KR100589872B1
(ko)
|
1997-05-30 |
2006-06-15 |
뉴로서치 에이/에스 |
8-아자비사이클로(3,2,1)옥트-2-엔 유도체 및 이의 제조방법
|
|
JP2002500652A
(ja)
|
1997-05-30 |
2002-01-08 |
ニューロサーアチ・アクティーゼルスカブ |
スピロ−キヌクリジン誘導体、その製造方法及びその使用方法
|
|
FR2765874B1
(fr)
|
1997-07-09 |
1999-08-13 |
Synthelabo |
Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
|
|
AR013184A1
(es)
|
1997-07-18 |
2000-12-13 |
Astrazeneca Ab |
Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
|
|
US6034079A
(en)
*
|
1997-08-11 |
2000-03-07 |
University Of South Florida |
Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
|
|
KR100607838B1
(ko)
|
1997-10-27 |
2006-08-04 |
뉴로서치 에이/에스 |
니코틴 작용성 아세틸콜린 수용체상의 콜린 작용성 리간드로서의 호모피페라진 유도체 및 이를 포함하는 약제학적 조성물
|
|
EP1034174B1
(en)
|
1997-11-05 |
2003-08-13 |
Neurosearch A/S |
Azaring-ether derivatives and their use as nicotinic ach receptor modulators
|
|
US6057446A
(en)
*
|
1998-04-02 |
2000-05-02 |
Crooks; Peter Anthony |
Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
|
|
EP0955301A3
(en)
|
1998-04-27 |
2001-04-18 |
Pfizer Products Inc. |
7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
|
|
US6211194B1
(en)
*
|
1998-04-30 |
2001-04-03 |
Duke University |
Solution containing nicotine
|
|
US6232316B1
(en)
*
|
1998-06-16 |
2001-05-15 |
Targacept, Inc. |
Methods for treatment of CNS disorders
|
|
US6368625B1
(en)
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
|
US6365182B1
(en)
|
1998-08-12 |
2002-04-02 |
Cima Labs Inc. |
Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
|
|
DE69919361T2
(de)
|
1998-08-25 |
2005-09-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridyl-ether und -thioether als nikotin-acetylcholin-rezeptorliganden und ihre therapeutische anwendung
|
|
US6262124B1
(en)
*
|
1998-10-22 |
2001-07-17 |
Gary Maurice Dull |
Pharmaceutical compositions and methods for use
|
|
DE69914935T2
(de)
|
1998-11-27 |
2009-10-01 |
Neurosearch A/S |
8-azabicyclo[3.2.1]okt-2-en- und -oktanderivate
|
|
FR2786770B1
(fr)
|
1998-12-04 |
2001-01-19 |
Synthelabo |
Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
|
|
FR2786769B1
(fr)
|
1998-12-04 |
2002-10-25 |
Synthelabo |
Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
|
|
DE69939498D1
(de)
*
|
1998-12-16 |
2008-10-16 |
Univ South Florida |
Exo-S-Mecamylamin-Formulierung
|
|
EP1147112B1
(en)
|
1999-01-29 |
2003-10-29 |
Abbott Laboratories |
Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
|
|
US6583160B2
(en)
*
|
1999-04-14 |
2003-06-24 |
Steve Smith |
Nicotine therapy method and oral carrier for assuaging tobacco-addiction
|
|
EP1175416B1
(en)
|
1999-04-26 |
2003-07-16 |
Neurosearch A/S |
Heteroaryl diazacycloalkanes, their preparation and use
|
|
NZ513575A
(en)
|
1999-05-04 |
2003-07-25 |
Neurosearch As |
Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
|
|
US20040229908A1
(en)
|
1999-07-13 |
2004-11-18 |
Jodi Nelson |
Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
|
|
US20080138399A1
(en)
*
|
1999-07-16 |
2008-06-12 |
Aradigm Corporation |
Dual release nicotine formulations, and systems and methods for their use
|
|
US20080138398A1
(en)
*
|
1999-07-16 |
2008-06-12 |
Aradigm Corporation |
Dual release nicotine formulations, and systems and methods for their use
|
|
US8256433B2
(en)
*
|
1999-07-16 |
2012-09-04 |
Aradigm Corporation |
Systems and methods for effecting cessation of tobacco use
|
|
US20080138294A1
(en)
*
|
1999-07-16 |
2008-06-12 |
Igor Gonda |
Systems and methods for effecting cessation of tobacco use
|
|
US6799576B2
(en)
*
|
1999-07-16 |
2004-10-05 |
Aradigm Corporation |
System for effecting smoking cessation
|
|
US8188043B2
(en)
*
|
1999-07-28 |
2012-05-29 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Nicotine in therapeutic angiogenesis and vasculogenesis
|
|
FR2798065B1
(fr)
*
|
1999-09-02 |
2003-09-05 |
Assist Publ Hopitaux De Paris |
Utilisation de la nicotine ou de ses derives dans un medicament pour le traitement des maladies neurologiques, notamment la maladie de parkinson
|
|
SE9903998D0
(sv)
*
|
1999-11-03 |
1999-11-03 |
Astra Ab |
New compounds
|
|
JP2001261652A
(ja)
*
|
2000-03-21 |
2001-09-26 |
Suntory Ltd |
二置換イミノヘテロサイクリック化合物
|
|
US6489025B2
(en)
*
|
2000-04-12 |
2002-12-03 |
Showa Denko K.K. |
Fine carbon fiber, method for producing the same and electrically conducting material comprising the fine carbon fiber
|
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
|
WO2002002081A1
(en)
|
2000-07-05 |
2002-01-10 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and methods of using same
|
|
GB0022084D0
(en)
*
|
2000-09-08 |
2000-10-25 |
Univ Aberdeen |
Treatment of multiply antibiotic-resistant organisms
|
|
AU2001292185A1
(en)
|
2000-10-12 |
2002-04-22 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
|
NZ528167A
(en)
|
2001-03-26 |
2005-04-29 |
Smithkline Beecham Corp |
Nicotine-containing oral dosage form
|
|
SE0102197D0
(sv)
*
|
2001-06-20 |
2001-06-20 |
Pharmacia Ab |
New product and use and manufacture thereof
|
|
SE0103211D0
(sv)
|
2001-09-27 |
2001-09-27 |
Pharmacia Ab |
New formulations and use thereof
|
|
US20030119879A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Thomas Landh |
Nicotine and chocolate compositions
|
|
US20030087937A1
(en)
*
|
2001-10-15 |
2003-05-08 |
Nils-Olof Lindberg |
Nicotine and cocoa powder compositions
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8329217B2
(en)
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
|
SE0104388D0
(sv)
|
2001-12-27 |
2001-12-27 |
Pharmacia Ab |
New formulation and use and manufacture thereof
|
|
US6852741B2
(en)
*
|
2001-12-31 |
2005-02-08 |
University Of Florida |
Compositions and methods for treatment of neurological disorders
|
|
CA2473536A1
(en)
|
2002-01-16 |
2003-07-31 |
Endo Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating disorders of the central nervous system
|
|
US20030159702A1
(en)
*
|
2002-01-21 |
2003-08-28 |
Lindell Katarina E.A. |
Formulation and use manufacture thereof
|
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
|
US7767698B2
(en)
*
|
2002-06-03 |
2010-08-03 |
Mcneil Ab |
Formulation and use thereof
|
|
PL376577A1
(pl)
|
2002-06-17 |
2006-01-09 |
Themis Laboratories Private Limited |
Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
|
|
US20040052851A1
(en)
*
|
2002-09-16 |
2004-03-18 |
Graff Allan H. |
Modified release oral dosage form
|
|
EP1578422B1
(en)
*
|
2002-12-20 |
2007-04-11 |
NicoNovum AB |
A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
|
|
SE0301320D0
(sv)
|
2003-05-06 |
2003-05-06 |
Astrazeneca Ab |
Positive modulators of nicotinic acetylcholine receptors
|
|
US20050159419A1
(en)
*
|
2003-05-14 |
2005-07-21 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
|
|
US7149574B2
(en)
*
|
2003-06-09 |
2006-12-12 |
Palo Alto Investors |
Treatment of conditions through electrical modulation of the autonomic nervous system
|
|
DE10338174A1
(de)
*
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
|
DK1663168T3
(da)
*
|
2003-09-08 |
2009-06-08 |
Mcneil Ab |
Nikotinformuleringer og anvendelse deraf
|
|
JP2007509146A
(ja)
*
|
2003-10-20 |
2007-04-12 |
テバ ファーマシューティカル インダストリーズ リミティド |
レボドーパの持続効果のための組成物及び投与形
|
|
US20050266032A1
(en)
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
CN1332667C
(zh)
*
|
2004-05-26 |
2007-08-22 |
中国科学院生物物理研究所 |
一种抗帕金森症（pd）复合制剂
|
|
JP2008525464A
(ja)
*
|
2004-12-22 |
2008-07-17 |
メモリー・ファーマシューティカルズ・コーポレイション |
α−７ニコチン性受容体リガンド並びにその製造及び使用
|
|
EP1942869A2
(en)
|
2005-11-04 |
2008-07-16 |
Eastman Chemical Company |
Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances
|
|
US7958887B2
(en)
*
|
2006-03-10 |
2011-06-14 |
Aradigm Corporation |
Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
|
|
AU2007224586A1
(en)
*
|
2006-03-16 |
2007-09-20 |
Niconovum Ab |
Stable lozenge compositions providing rapid release of nicotine
|
|
US20070269492A1
(en)
|
2006-05-16 |
2007-11-22 |
Per Steen |
New product and use and manufacture thereof
|
|
EP1977746B8
(en)
*
|
2007-04-02 |
2014-09-24 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|